Dear John,

This week, Health Affairs released an ahead-of-print article by Rory Smith and colleagues at Brown University.

The article, part of the upcoming December 2023 issue on Global Lessons from COVID-19, explores global efforts to counter misinformation during the COVID-19 pandemic.

Smith and coauthors analyze fifty papers published between January 2020 and February 2023 to determine evidence of efficacy in COVID-19 misinformation mitigation policies.

After categorizing interventions present in the papers examined into twelve types of interventions. Smith and colleagues determine that “there is no silver bullet for mitigating health misinformation.”

Instead, to better discern the effects of intervention designs, Smith and colleagues recommend that public health experts be included in intervention design and develop a health misinformation typology, among other recommendations.

The IRA Expanded Access To Adult Immunization, But There Are Opportunities To Do More

Alessandra Fix et al.

What’s The Worst That Could Happen? A Toothless FDA

Holly Fernandez Lynch et al.

CBO Report Highlights Need For Change Of Direction In Health Policy

Brian C. Blase

Leveraging US Emergency Departments To Help End The HIV Epidemic

Christopher L Bennett and Allan S. Detsky

In An Era Of Premium And Provider Price Increases, State Employee Health Plans Target Key Cost Drivers

Sabrina Corlette and Karen Davenport

The Elusive Quest For Value: Getting The Details Right

Richard F. Averill

A Promising Turning Point For Dementia Care: The GUIDE Model

Rajiv Ahuja and Diane Ty

How Will The Executive Order On Artificial Intelligence Impact Health Care?

Jodi G. Daniel and Harlan M. Krumholz

We Need Better Data, Not Just New Drugs, To Reduce Disparities In Alzheimer’s Care

Daniel A. Ollendorf

The AI Executive Order and Why Health Care Should Care

Health Affairs' Ellen Bayer and Chris Fleming interview Harlan Krumholz from the Yale School of Medicine about President Biden's executive order on artificial intelligence and the implications for health care.

Later this month, join us for the following events:

• November 27: Journal Club: Studies Of Prescription Digital Therapeutics Often Lack Rigor And Inclusivity
• November 28: Policy Spotlight: One-on-One with Nora Volkow, Director, National Institute on Drug Abuse at the National Institutes of Health